Ayala Pharmaceuticals Profit Margin

Ayala Pharmaceuticals (AYLA) currently reports a profit margin of -5493.21% as of December 2022. That is below the Healthcare sector average of 21.34%. Use the charts on this page to explore Ayala Pharmaceuticals's profit margin history and peer comparisons.

Ayala Pharmaceuticals's profit margin of -5493.21% is lower than the Healthcare sector average of 21.34%. That is roughly 25847.2% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Ayala Pharmaceuticals's current -5493.21% should be judged against Healthcare norms (sector average: 21.34%) and against AYLA's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -5493.21%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 21.34%. From there, open related valuation or income-statement pages for Ayala Pharmaceuticals, and consider following AYLA for alerts when major investors trade the stock.

Ayala Pharmaceuticals is classified in the Healthcare sector. On profit margin, it currently shows -5493.21% versus a sector average near 21.34%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AYLA with unrelated industries.